DATE: February 15, 2011
LENGTH: 30 minutes
Did you know that FDA plays a vital role in ensuring the safety of the nation’s blood supply?
On Tuesday, February 15th, at 2 p.m. ET, FDA hosted a webinar that addressed how the agency safeguards the nation’s blood supply and protects the five million people who receive blood transfusions annually. Richard Davey, MD, Director of the Division of Blood Applications, Office of Blood Research and Review in FDA’s Center for Biologics Evaluation and Research, discussed the five overlapping layers of blood safety and review current FDA regulations and recommendations established to ensure a safe and available blood supply. Dr. Davey provided an overview of these safeguards and will focus on the donor screening process and the testing of blood for blood-borne infectious agents. He also discussed steps to insure transfusion safety in the hospital setting.
Download Presentation Slides:
FDA Basics Webinar: Safety of the Blood Supply (PDF 830KB)
View an archived version of the presentation.
- FDA Webinar on Protecting Your Child's Health Through Safe and Effective Vaccines
- FDA Webinar on Safety of the Blood Supply
- What are stem cells? How are they regulated?
- What is a biological product?
- Webinar on FDA’s Safety Monitoring of Approved Vaccines
- What is thimerosal? Is it safe when used in some vaccines?
- How can I get my name removed from a donor deferral list?
- How does FDA regulate tissue products? What safeguards are in place for recipients?
- How do I know if I’m eligible to donate blood?
- What is the Vaccine Adverse Event Reporting System (VAERS)?
- What is the approval process for a biological product?
- How do I report an adverse event related to a vaccine?
- How does FDA assess the safety of vaccines?